Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

Abstract During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient. Despite focused efforts to achieve this balance, the frequency of both thrombotic...

Full description

Bibliographic Details
Main Authors: Meghan M. Chlebowski, Sirine Baltagi, Mel Carlson, Jerrold H. Levy, Philip C. Spinella
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Critical Care
Subjects:
Online Access:https://doi.org/10.1186/s13054-020-2726-9
id doaj-dcad27ce40f445f39dd9bd2c1047c4ed
record_format Article
spelling doaj-dcad27ce40f445f39dd9bd2c1047c4ed2021-01-24T12:18:41ZengBMCCritical Care1364-85352020-01-0124111210.1186/s13054-020-2726-9Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMOMeghan M. Chlebowski0Sirine Baltagi1Mel Carlson2Jerrold H. Levy3Philip C. Spinella4Department of Pediatrics, Division of Pediatric Cardiology, Cardiovascular Intensive Care Unit, Cincinnati Children’s Hospital/University of Cincinnati College of MedicineDepartment of Pediatrics, Division of Critical Care Medicine, St. Joseph’s Children’s Hospital/University of Pittsburg School of MedicineLFB-USADepartment of Anesthesiology, Critical Care, and Surgery, Duke University School of MedicineDepartment of Pediatrics, Division of Pediatric Critical Care Medicine, Washington University School of MedicineAbstract During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient. Despite focused efforts to achieve this balance, the frequency of both thrombotic and bleeding events remains high. Anticoagulation is complicated to manage in this population due to the complexities of the hemostatic system that are compounded by age-related developmental hemostatic changes, variable effects of the etiology of critical illness on hemostasis, and blood-circuit interaction. Lack of high-quality data to guide anticoagulation management in ECMO patients results in marked practice variability among centers. One aspect of anticoagulation therapy that is particularly challenging is the use of antithrombin (AT) supplementation for heparin resistance. This is especially controversial in the neonatal and pediatric population due to the baseline higher risk of bleeding in this cohort. The indication for AT supplementation is further compounded by the potential inaccuracy of the diagnosis of heparin resistance based on the standard laboratory parameters used to assess heparin effect. With concerns regarding the adverse impact of bleeding and thrombosis, clinicians and institutions are faced with making difficult, real-time decisions aimed at optimizing anticoagulation in this setting. In this clinically focused review, the authors discuss the complexities of anticoagulation monitoring and therapeutic intervention for patients on ECMO and examine the challenges surrounding AT supplementation given both the historical and current perspectives summarized in the literature on these topics.https://doi.org/10.1186/s13054-020-2726-9AnticoagulationAntithrombinExtracorporeal membrane oxygenation
collection DOAJ
language English
format Article
sources DOAJ
author Meghan M. Chlebowski
Sirine Baltagi
Mel Carlson
Jerrold H. Levy
Philip C. Spinella
spellingShingle Meghan M. Chlebowski
Sirine Baltagi
Mel Carlson
Jerrold H. Levy
Philip C. Spinella
Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
Critical Care
Anticoagulation
Antithrombin
Extracorporeal membrane oxygenation
author_facet Meghan M. Chlebowski
Sirine Baltagi
Mel Carlson
Jerrold H. Levy
Philip C. Spinella
author_sort Meghan M. Chlebowski
title Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
title_short Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
title_full Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
title_fullStr Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
title_full_unstemmed Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO
title_sort clinical controversies in anticoagulation monitoring and antithrombin supplementation for ecmo
publisher BMC
series Critical Care
issn 1364-8535
publishDate 2020-01-01
description Abstract During extracorporeal membrane oxygenation (ECMO), a delicate balance is required to titrate systemic anticoagulation to prevent thrombotic complications within the circuit and prevent bleeding in the patient. Despite focused efforts to achieve this balance, the frequency of both thrombotic and bleeding events remains high. Anticoagulation is complicated to manage in this population due to the complexities of the hemostatic system that are compounded by age-related developmental hemostatic changes, variable effects of the etiology of critical illness on hemostasis, and blood-circuit interaction. Lack of high-quality data to guide anticoagulation management in ECMO patients results in marked practice variability among centers. One aspect of anticoagulation therapy that is particularly challenging is the use of antithrombin (AT) supplementation for heparin resistance. This is especially controversial in the neonatal and pediatric population due to the baseline higher risk of bleeding in this cohort. The indication for AT supplementation is further compounded by the potential inaccuracy of the diagnosis of heparin resistance based on the standard laboratory parameters used to assess heparin effect. With concerns regarding the adverse impact of bleeding and thrombosis, clinicians and institutions are faced with making difficult, real-time decisions aimed at optimizing anticoagulation in this setting. In this clinically focused review, the authors discuss the complexities of anticoagulation monitoring and therapeutic intervention for patients on ECMO and examine the challenges surrounding AT supplementation given both the historical and current perspectives summarized in the literature on these topics.
topic Anticoagulation
Antithrombin
Extracorporeal membrane oxygenation
url https://doi.org/10.1186/s13054-020-2726-9
work_keys_str_mv AT meghanmchlebowski clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo
AT sirinebaltagi clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo
AT melcarlson clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo
AT jerroldhlevy clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo
AT philipcspinella clinicalcontroversiesinanticoagulationmonitoringandantithrombinsupplementationforecmo
_version_ 1724326065866801152